Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia - de Jonge, E; Dekkers, PE; Creasey, AA; Hack, CE; Paulson, SK; Karim, A; Kesecioglu, J; Levi, M; van Deventer, SJ; van der Poll, T (Blood, 2000)